Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
James River Group
JRVR
$246M
| $1.49M | ﹤0.01% |
81,699
+800
| +1% | +$14.6K |
|
2077
Mesa Laboratories
MLAB
$337M
| $1.49M | ﹤0.01% |
11,602
+100
| +0.9% | +$12.9K |
|
2078
Alkami Technology
ALKT
$2.62B
| $1.49M | ﹤0.01% |
90,900
+51,500
| +131% | +$844K |
|
2079
Kimball Electronics
KE
$743M
| $1.49M | ﹤0.01% |
53,900
+600
| +1% | +$16.6K |
|
|
DSEY
2080
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $1.48M | ﹤0.01% |
176,700
+1,700
| +1% | +$14.3K |
|
2081
Crinetics Pharmaceuticals
CRNX
$3.21B
| $1.48M | ﹤0.01% |
82,200
+900
| +1% | +$16.2K |
|
2082
Gorman-Rupp
GRC
$1.14B
| $1.48M | ﹤0.01% |
51,347
+6,300
| +14% | +$182K |
|
2083
Douglas Dynamics
PLOW
$764M
| $1.48M | ﹤0.01% |
49,400
| – | – |
|
|
DX
2084
Dynex Capital
DX
$1.65B
| $1.48M | ﹤0.01% |
117,233
+17,200
| +17% | +$217K |
|
2085
Vita Coco
COCO
$2.2B
| $1.48M | ﹤0.01% |
54,900
+24,700
| +82% | +$664K |
|
2086
Sphere Entertainment
SPHR
$2.06B
| $1.47M | ﹤0.01% |
53,759
| – | – |
|
2087
Adaptive Biotechnologies
ADPT
$2.05B
| $1.46M | ﹤0.01% |
218,300
+2,300
| +1% | +$15.4K |
|
|
INBX
2088
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.46M | ﹤0.01% |
56,400
| – | – |
|
2089
Select Water Solutions
WTTR
$943M
| $1.46M | ﹤0.01% |
180,700
+43,100
| +31% | +$349K |
|
|
NAPA
2090
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $1.46M | ﹤0.01% |
112,800
+25,800
| +30% | +$335K |
|
2091
Brookdale Senior Living
BKD
$1.76B
| $1.46M | ﹤0.01% |
346,439
-16,400
| -5% | -$69.2K |
|
2092
Editas Medicine
EDIT
$245M
| $1.46M | ﹤0.01% |
177,300
+28,900
| +19% | +$238K |
|
2093
nLIGHT
LASR
$1.47B
| $1.46M | ﹤0.01% |
94,500
-3,300
| -3% | -$50.9K |
|
|
PDS
2094
Precision Drilling
PDS
$749M
| $1.46M | ﹤0.01% |
29,800
+400
| +1% | +$19.5K |
|
2095
Revolve Group
RVLV
$1.72B
| $1.46M | ﹤0.01% |
88,800
+900
| +1% | +$14.8K |
|
2096
Avidity Biosciences
RNA
$4.81B
| $1.45M | ﹤0.01% |
131,000
+16,200
| +14% | +$180K |
|
2097
Tidewater
TDW
$2.99B
| $1.45M | ﹤0.01% |
26,200
| – | – |
|
2098
Informatica
INFA
$7.55B
| $1.45M | ﹤0.01% |
78,400
+1,000
| +1% | +$18.5K |
|
2099
Stagwell
STGW
$1.43B
| $1.45M | ﹤0.01% |
200,600
+3,000
| +2% | +$21.6K |
|
2100
Anywhere Real Estate
HOUS
$729M
| $1.44M | ﹤0.01% |
216,200
-20,100
| -9% | -$134K |
|